Executive Decision Making - 2020

A CONFERENCE FOR BIOPHARMA EXECUTIVES AT THE INTERSECTION OF SCIENCE, BUSINESS, AND OPERATIONS

In a highly competitive and often uncertain drug development landscape, it is important for pharma, biotech, and device companies to continuously optimize their strategy, evaluate their portfolios, improve decision making, reduce risk, and effectively deploy resources. Cambridge Healthtech Institute and the BioPharma Strategy Series present Executive Decision Making 2020, 5 days of high-level content, interactive discussions and networking. This executive forum unites R&D executives from the biopharma community to share best practices in project and portfolio management, R&D innovation, decision analysis, forecasting, and resource management. Attendees will gain strategic insights and proven tools, methods, and perspectives from a variety of leaders at the intersection of science, business, and operations.